Victrix Investment Advisors
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2055229
Stuart, FL
Position in REGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,971,791
-$710,611 QoQ
Shares Held
4,766
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#459
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Victrix Investment Advisors holds $3,241,377 across 2 Biotechnology names. REGN ranks #1 (91.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,766 | $2,971,791 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
3,400 | $269,586 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,971,791 | 4,766 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $3,682,402 | 4,766 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $3,782,163 | 4,900 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,755,123 | 4,900 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,572,500 | 4,900 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,107,727 | 4,900 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,490,417 | 4,900 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||